Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2007 Aug;99(8):933–936.

Dialysis access thrombosis in a family cohort.

Arash Bornak 1, Lee Kirksey 1
PMCID: PMC2574299  PMID: 17722673

Abstract

In 2004, 464,952 individuals were newly diagnosed with chronic renal insufficiency (CRI); 102,356 of those newly diagnosed patients required initiation of dialysis for end-stage renal disease (ESRD). Among the ESRD population, about one third is African American despite the fact that this population represent only about 12% of the total population in the United States (U.S. Renal Data System 2006). Familial aggregation of kidney disease disproportionately affects minorities. This paper describes the detection and management of dialysis access failure due to hypercoagulable states in a genetically related group. We also discuss the implications that associated familial disorders may have on the diagnoses, treatment and survival for this devastating illness.

Full text

PDF
933

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asif Arif, Gadalean Florin N., Merrill Donna, Cherla Gautam, Cipleu Cristian D., Epstein David L., Roth David. Inflow stenosis in arteriovenous fistulas and grafts: a multicenter, prospective study. Kidney Int. 2005 May;67(5):1986–1992. doi: 10.1111/j.1523-1755.2005.00299.x. [DOI] [PubMed] [Google Scholar]
  2. Baskin E., Duman O., Beşbaş N., Ozen S. Hypercoagulopathy in a hemodialysis patient: are elevations in factors VII and VIII effective? Nephron. 1999;83(2):180–180. doi: 10.1159/000045504. [DOI] [PubMed] [Google Scholar]
  3. Churchill D. N., Taylor D. W., Cook R. J., LaPlante P., Barre P., Cartier P., Fay W. P., Goldstein M. B., Jindal K., Mandin H. Canadian Hemodialysis Morbidity Study. Am J Kidney Dis. 1992 Mar;19(3):214–234. doi: 10.1016/s0272-6386(13)80002-9. [DOI] [PubMed] [Google Scholar]
  4. Dossabhoy Neville R., Ram Sunanda J., Nassar Raja, Work Jack, Eason J. Mark, Paulson William D. Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Semin Dial. 2005 Nov-Dec;18(6):550–557. doi: 10.1111/j.1525-139X.2005.00102.x. [DOI] [PubMed] [Google Scholar]
  5. Dy G. R., Bloom E. J., Ijelu G. K., Merritts G. W., Kramer M. S., Raja R. M. Effect of recombinant human erythropoietin on vascular access. ASAIO Trans. 1991 Jul-Sep;37(3):M274–M275. [PubMed] [Google Scholar]
  6. Fan P. Y., Schwab S. J. Vascular access: concepts for the 1990s. J Am Soc Nephrol. 1992 Jul;3(1):1–11. doi: 10.1681/ASN.V311. [DOI] [PubMed] [Google Scholar]
  7. Fihn S. D., McDonell M., Martin D., Henikoff J., Vermes D., Kent D., White R. H. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med. 1993 Apr 1;118(7):511–520. doi: 10.7326/0003-4819-118-7-199304010-00005. [DOI] [PubMed] [Google Scholar]
  8. Freedman B. I., Soucie J. M., McClellan W. M. Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol. 1997 Dec;8(12):1942–1945. doi: 10.1681/ASN.V8121942. [DOI] [PubMed] [Google Scholar]
  9. Henry Mitchell L. Routine surveillance in vascular access for hemodialysis. Eur J Vasc Endovasc Surg. 2006 Aug 24;32(5):545–548. doi: 10.1016/j.ejvs.2006.05.003. [DOI] [PubMed] [Google Scholar]
  10. Hoeben Heidi, Abu-Alfa Ali K., Reilly Robert F., Aruny John E., Bouman Koenraad, Perazella Mark A. Vascular access surveillance: evaluation of combining dynamic venous pressure and vascular access blood flow measurements. Am J Nephrol. 2003 Oct 17;23(6):403–408. doi: 10.1159/000074297. [DOI] [PubMed] [Google Scholar]
  11. Knoll Greg A., Wells Philip S., Young Darlene, Perkins Sherry L., Pilkey Rachel M., Clinch Jennifer J., Rodger Marc A. Thrombophilia and the risk for hemodialysis vascular access thrombosis. J Am Soc Nephrol. 2005 Feb 23;16(4):1108–1114. doi: 10.1681/ASN.2004110999. [DOI] [PubMed] [Google Scholar]
  12. LeSar C. J., Merrick H. W., Smith M. R. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access. J Am Coll Surg. 1999 Jul;189(1):73–81. doi: 10.1016/s1072-7515(99)00086-1. [DOI] [PubMed] [Google Scholar]
  13. Li Suying, McAlpine Donna D., Liu Jiannong, Li Shuling, Collins Allan J. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Adv Ren Replace Ther. 2004 Jan;11(1):5–13. doi: 10.1053/j.arrt.2003.10.005. [DOI] [PubMed] [Google Scholar]
  14. O'shea Susan I., Lawson Jeffrey H., Reddan Donal, Murphy Michael, Ortel Thomas L. Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. J Vasc Surg. 2003 Sep;38(3):541–548. doi: 10.1016/s0741-5214(03)00321-5. [DOI] [PubMed] [Google Scholar]
  15. Prakash R., Miller C. C., 3rd, Suki W. N. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am J Kidney Dis. 1995 Aug;26(2):347–352. doi: 10.1016/0272-6386(95)90656-8. [DOI] [PubMed] [Google Scholar]
  16. Windus D. W., Jendrisak M. D., Delmez J. A. Prosthetic fistula survival and complications in hemodialysis patients: effects of diabetes and age. Am J Kidney Dis. 1992 May;19(5):448–452. doi: 10.1016/s0272-6386(12)80953-x. [DOI] [PubMed] [Google Scholar]
  17. Windus D. W. Permanent vascular access: a nephrologist's view. Am J Kidney Dis. 1993 May;21(5):457–471. doi: 10.1016/s0272-6386(12)80391-x. [DOI] [PubMed] [Google Scholar]
  18. Xue J. L., Ma J. Z., Louis T. A., Collins A. J. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol. 2001 Dec;12(12):2753–2758. doi: 10.1681/ASN.V12122753. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES